期刊文献+

结直肠癌根治性手术后复发时间与生存时间的相关性分析 被引量:5

The relationship between time to relapse and survival after curative surgery in colorectal cancer patients
下载PDF
导出
摘要 背景与目的:结直肠癌根治性手术后复发率达30%-40%,肿瘤复发影响患者生存时间。本研究旨在探讨结直肠癌复发时间(time to relapse,TTR)与肿瘤临床病理参数的关系,并进一步分析TTR对复发后生存时间的影响。方法:分析辽宁省肿瘤医院收治的375例结直肠癌患者的临床资料、病理结果及随访数据,比较结直肠癌复发与临床资料和病理类型的相关性,并研究TTR与复发后总体生存时间的关系。结果:TTR与确诊时肿瘤分期以及有无肺、肝脏转移密切相关。短期复发(〈2年)与生存时间密切相关,2-5年内复发与5年以上复发的患者,其生存时间差异无统计学意义(P〉0.05)。结论:结直肠癌患者术后复发时间与肿瘤分期及有无肺、肝脏转移密切相关,短期复发是预测复发后生存时间的重要指标。 Background and purpose: The risk of recurrence for colorectal cancer after curative surgery is up to 30%-40%. We aimed to evaluate the relationship between time to relapse (TTR) of colorectal cancer with clinical pathological parameters and overall survival after recurrence. Methods: We carried out the analysis of clinical data, pathological examination and follow up information of 375 colorectal cancer patients who admitted to Liaoning Cancer Hospital. Patients were categorized into relapse at 〈2, 2-5 and 〉5 years following their initial surgery. Results: TTR was associated with the clinical stage at diagnosis and liver or lung metastasis status. Short TTR (〈2 years) was positively associated with survival. However, there was no significant difference in survival between patients who relapsed at 5 years or later compared with those who relapsed between 2 and 5 years. Conclusion: TTR within 2 years is an important predictor of shorter survival for colorectal cancer patients who experienced a relapse.
出处 《中国癌症杂志》 CAS CSCD 北大核心 2013年第10期841-844,共4页 China Oncology
基金 辽宁省教育厅课题(No:L2012295)
关键词 结直肠癌 复发 生存时间 Colorectal cancer Time to relapse Overall survival
  • 相关文献

参考文献9

  • 1YEOH K G, HO K Y, CHIU H M, et al. The Asia-Pacific colorectal screening score: A validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects [ J ] . Gut, 2011, 60(9): 1236-1241.
  • 2DELBE K E D, MARTIN W H. PE and PET-CT for evaluation of colorectal carcinoma [ J ]. Semin Nucl Med, 2004, 34(3): 209-223.
  • 3SARGENT D, SOBRERO A, GROTHEY A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials [ J ] . J Clin Oncol, 2009, 27(6): 872-877.
  • 4O' CONNELL J B, MAGGARD M A, KO C Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging [ J 1 J Natl Cancer Inst, 2004, 96(19): 1420-1425.
  • 5DESCH C E, BENSON A B, SOMERSFIELD M R, et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline [ J ] . J Clin Oncol, 2005, 23(33): 8512-8519.
  • 6BRULE S Y, JONKER D J, KARAPETIS C S, et al. Location of colon cancer (right-sided [ RC ] versus left-sided [ LC ] ) as a predictor of benefit from cetuximab (CET): NCIC CTG CO.17 [ J ] . J Clin Oncol, 2013, 31(suppl): abstr 35280.
  • 7MISSIAGLIA E, JACOBS B, DI NARZO A F, et al. Proximal and distal colon tumors as distinct biologic entities with different prognoses [ J ]. J Clin Oncol, 2013, 31(suppl): abstr 3526.
  • 8GONZALEZ M, ROBERT J II, HALKIC N, et al. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases [ J ] . World J Surg, 2012, 36(2): 386-391.
  • 9KAISER A M, KANG J C, CHAN LS, BEART R W. The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer [ J ] . Colorectal Dis, 2006, 8(8): 696-703.

同被引文献51

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部